| Identification | Back Directory | [Name]
L-Phenylalanine, L-alanyl-L-prolyl-L-arginyl-L-seryl-L-methionyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-α-aspartyl-L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl- | [CAS]
309245-16-7 | [Synonyms]
L-Phenylalanine, L-alanyl-L-prolyl-L-arginyl-L-seryl-L-methionyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-α-aspartyl-L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl- | [Molecular Formula]
C131H217N49O41S4 | [MOL File]
309245-16-7.mol | [Molecular Weight]
3262.69 |
| Hazard Information | Back Directory | [Uses]
ANP (1-30), frog is a peptide fragment of atrial natriuretic peptide derived from frog. ANP (1-30), frog has natriuretic, diuretic, and vasorelaxant effects. | [References]
[1] Cannone V, et al. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease. Int J Mol Sci. 2019 Jul 2;20(13):3265. DOI:10.3390/ijms20133265 |
|
|